“Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients” (2015) Bangladesh Journal of Pharmacology, 10(3), pp. 489–493. doi:10.3329/bjp.v10i3.23079.